Cadherin and catenin alterations in human cancer. - Wikidata - awgldk - TriplyDB

Cadherin and catenin alterations in human cancer.

Cadherin and catenin alterations in human cancer.

http://www.wikidata.org/entity/Q34128162

about

Negative regulation of the expressions of cytokeratins 8 and 19 by SLUG repressor protein in human breast cells Characterization of cadherin-24, a novel alternatively spliced type II cadherin Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK Role of APC and DNA mismatch repair genes in the development of colorectal cancers.E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases Epigenetics of cervical cancer. An overview and therapeutic perspectives MicroRNA Regulation of Epithelial to Mesenchymal Transition DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity Interactions between E-cadherin and microRNA deregulation in head and neck cancers: the potential interplay Adhesion molecules in breast carcinoma: a challenge to the pathologist Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma Anoikis resistance: an essential prerequisite for tumor metastasis Identification of novel cholesteatoma-related gene expression signatures using full-genome microarrays N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics.Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer.Heritable and lineage-specific gene knockdown in zebrafish embryo WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series.Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?Prognostic relevance of β-catenin expression in T2-3N0M0 esophageal squamous cell carcinoma Clinico-pathological correlation of E-cadherin expression at the invasive tumor front of Indian oral squamous cell carcinomas: An immunohistochemical study.Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium Benzo pyrene-induced DNA adducts and gene expression profiles in target and non-target organs for carcinogenesis in mice.Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex.Current trends in the management of extra-abdominal desmoid tumours Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells.Characterization of β-catenin expression in canine osteosarcoma Analysis of metastasis suppressing function of E-cadherin in gastric cancer cells by RNAi.Combination of rapamycin, CI-1040, and 17-AAG inhibits metastatic capacity of prostate cancer via Slug inhibition.Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner The cadherin-catenin complex in nasopharyngeal carcinoma

P2860

Q24296997-D708BE7D-7D16-4732-91A8-C94C9B9BB520 Q24301428-71D28367-E124-4692-B181-3506818A5FDE Q24301523-03CD3F9F-5F6D-4007-A245-38F11F64C1E9 Q24319134-9A6215FB-AE93-4E94-B02A-C470AFD897C1 Q24672084-DD2F5677-BA45-4069-9D71-9959648890F2 Q24806345-8F5C485F-B33E-44D4-8819-CEA946F0E474 Q24811225-C803892A-83B4-4FEB-9639-65E57E85A614 Q24812104-DC2335CC-98EE-4A5F-A709-CD5A8D252158 Q26771110-13D8462C-B889-4D3C-9D78-F79F71D30E5F Q26825789-E4C01E79-C8C5-4F5A-8FA0-A91FD899A023 Q26866533-F13E5726-6676-4E88-B398-E0F8A52FC747 Q26996638-F77D256A-3B13-46A3-BEA1-F6FCD4D13987 Q27478395-DF33EC1B-A01B-4948-A263-4A2F2836593D Q28397372-DF5A57E8-3989-46BD-B64A-BE73340C5A2D Q28484501-C9C1E329-F3FD-4172-A57C-7B99EEE0B179 Q28591916-AF108164-1AA9-4AF2-8B0F-7E5AC36EDBD9 Q28972461-1074CD6A-4458-4CF9-8A79-A1A14B128A90 Q30499765-E127F9E9-9AF9-4CDE-9FF7-73401B3C3B98 Q33394061-0AB4C68D-F50B-4677-9139-DF2A138FA058 Q33479155-264F6F23-5636-4E75-836F-04EBA9D2B258 Q33572324-8DA9315D-0CBB-40D7-BF8E-64BB26ED74A1 Q33659798-486A15CC-9C94-4F3B-8588-81E01C621E9D Q33726412-B2853C16-D639-48A8-ADFE-93631D9BBEE3 Q34284749-4815696E-CCE6-42F7-8269-C551FD49C3F8 Q34335002-E06A875A-D9FD-4DA1-8455-901B4C4CBA31 Q34387983-C5F701D8-F115-412A-80F3-2F1FF29266E5 Q34402066-BE103D26-3853-423F-957C-6A6F7F81621F Q34550834-6E314ECE-EF34-4721-90E0-B077D1310DB7 Q34590630-35F72458-2FBE-4061-A838-F42F05198C5D Q34648726-01DB0578-D27C-4825-98F8-99176F03D4BB Q34768295-4A25773A-FD59-43EC-A5F7-7D70E546B3AE Q34768320-A6E1D02F-C4F6-451F-BE00-39FEF9F15AA9 Q34807135-A0CDBF8A-13E1-48E5-BD82-C347B267ED5B Q34807663-D3CF6666-20A2-440C-A6DB-00532D3CFFD8 Q34997146-1C2CDB3F-AC4D-48CD-AC9C-EF0C4B6C0879 Q35010551-D9C6A84B-2505-4632-89AF-4AEE075B66C9 Q35018858-4AB3C2F7-B6AC-45CD-AE8D-3C9856AA4551 Q35027292-10EF314D-D098-43EC-963B-C62C5C2EC982 Q35067315-552D2FA9-B4F2-4781-9F21-FE4AD174E907 Q35145996-C6D61F38-69D5-441F-B825-EB9D15CDBDF8

P2860

Cadherin and catenin alterations in human cancer.

http://www.wikidata.org/entity/Q34128162

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Cadherin and catenin alterations in human cancer.

@ast

Cadherin and catenin alterations in human cancer.

@en

Cadherin and catenin alterations in human cancer.

@nl

type

label

Cadherin and catenin alterations in human cancer.

@ast

Cadherin and catenin alterations in human cancer.

@en

Cadherin and catenin alterations in human cancer.

@nl

prefLabel

Cadherin and catenin alterations in human cancer.

@ast

Cadherin and catenin alterations in human cancer.

@en

Cadherin and catenin alterations in human cancer.

@nl

P1433

Q34128162-CB071A6B-57F8-4E38-BA59-9320B4AB286A

P1476

Q34128162-5B5D063B-435E-4683-A8A6-BED015F43A87

P2093

Q34128162-386C9964-E9FF-415E-8B11-F54AA117D8B2

Q34128162-6C9D9D6E-E7F0-4860-92B1-C90B42AEC268

P2860

Q34128162-0951C43E-4F68-44CC-8710-439273281EFC

Q34128162-09F30B2D-4376-4E9E-AE72-19DEEE44B685

Q34128162-10C28E9B-0128-4A6F-BCF7-DC05E7D1E79F

Q34128162-12DC812A-05AA-45DA-9D07-F406E570743C

Q34128162-1371262B-C33F-49A7-9F60-6C2EE2EB5322

Q34128162-18101A5A-F458-43DF-8757-87150826948B

Q34128162-1D77D752-9030-4BB5-8DBC-89622C65263C

Q34128162-1E252D85-3D4D-4803-824C-F0836EC48E33

Q34128162-1EBAE352-A79A-48F1-9C8E-6D1608EAEBBB

Q34128162-1F84C32D-CBE8-43AF-9878-E5F07587773D

P304

Q34128162-9515685B-678D-4A85-86E1-00F40DB4B853

P31

Q34128162-991B1417-6FF1-4639-99FE-557954C5282A

P356

Q34128162-BF6C4999-45AA-4C4A-BCCC-83134E6EC4E9

P433

Q34128162-6CA9D4B1-E4C6-4847-8911-1A8D60B6C6CC

P478

Q34128162-B3A84255-E5A1-4234-B4B9-1C9D2320BF53

P577

Q34128162-173AADFF-AD91-4486-988F-A988E1C3CCAA

P5875

Q34128162-C22BC952-B689-499B-93F2-1FF4B7CCF279

P698

Q34128162-1F1C4562-6C6C-41C8-9898-6AB78C901445

P356

P1433

Genes, Chromosomes and Cancer

P1476

Cadherin and catenin alterations in human cancer.

@en

P2093

Eric R Fearon

http://www.w3.org/2001/XMLSchema#string

Karen M Hajra

http://www.w3.org/2001/XMLSchema#string

P2860

The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor

Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling

Cloning of the human alpha-catenin cDNA and its aberrant mRNA in a human cancer cell line

Identification of c-MYC as a target of the APC pathway

The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin

E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton

The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers

Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo

Structural basis of calcium-induced E-cadherin rigidification and dimerization

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

P304

255-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GCC.10083

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11364413

http://www.w3.org/2001/XMLSchema#string

P698

12007186

http://www.w3.org/2001/XMLSchema#string